Development And External Validation Of A Risk Calculator For Predicting Anemia In Patients Treated With Triple Therapy (Tt) Containing Boceprevir (Boc), Pegylated Interferon And Ribavirin (Pr)
Abstract
Authors
C. Nwankwo M. Kattan A. Luan J. Wahl